Edgewise Therapeutics stock has undergone multiple analysts rating changes in the recent past. Edgewise Therapeutics Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.
Shares of Edgewise Therapeutics traded up $0.30 on Tuesday, reaching $17.30. 0 shares of the stock traded hands, compared to its average volume of 74732. Shares of Edgewise Therapeutics were trading at $17.30 on Tuesday. The firm’s 50 day moving average is $16.81 and its 200 day moving average is N/A.Edgewise Therapeutics has a 12 month low of $16.12 and a 12 month high of $40.49. While on yearly highs and lows, Edgewise Therapeutics’s today has traded high as $17.73 and has touched $16.12 on the downward trend. See More Analyst Rating at: RATING
Edgewise Therapeutics Earnings and What to expect:
Edgewise Therapeutics last released its earnings data on August 9th, 2021. The reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.04. Edgewise Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Edgewise Therapeutics are expected to decrease in the coming year, from ($0.85) to ($1.18) per share. Edgewise Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 8th, 2021 based off prior year’s report dates.
Earnings for Edgewise Therapeutics are expected to decrease in the coming year, from ($0.85) to ($1.18) per share.
Edgewise Therapeutics (NASDAQ:EWTX) Moving Average Technical Analysis
5 day Moving Average is $17.92 And 5 day price change is -$1.12 (-6.08%) with average volume for 5 day average is 100,400. While technical analysis for average 20 days shows significant difference, 20 day moving average is $17.65 and 20 day price change is $0.39 (2.31%) and average 20 day moving volume is 89,600. 50 day moving average is $16.81 and 50 day price change is -$0.14 ( -0.80%) and with average volume for 50 days is : 66,968. 200 day moving average is N/A and 200 day price change is N/A (N/A) and with average volume for 200 days is : N/A.
Other owners latest trading in Edgewise Therapeutics :
- On 8/17/2021 shares held by Woodline Partners LP were 354,489 which equates to market value of $7.56M and appx 0.10% owners of Edgewise Therapeutics
- On 8/17/2021 shares held by Logos Global Management LP were 1,231,812 which equates to market value of $26.28M and appx 2.20% owners of Edgewise Therapeutics
- On 8/17/2021 shares held by Citadel Advisors LLC were 2,460,151 which equates to market value of $51.20M and appx 0.00% owners of Edgewise Therapeutics
- In total Institutional ownership equates to Institutional Ownership Percentage: 96.58% for Edgewise Therapeutics
See More Analyst Rating at: RATING